References
- Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Nice Clinical Guideline. 2010.
- Newby DE, Adamson PD, Berry C, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018 Sep;379(10):924–933.
- Hoffmann U, Ferencik M, Udelson JE, et al. Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (prospective multicenter imaging study for evaluation of chest pain). Circulation. 2017 Jun;135(24):2320–2332.
- Gray AJ, Roobottom C, Smith JE, et al. Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial. BMJ. 2021 Sep;374:n2106. doi: 10.1136/bmj.n2106
- Hecht HS, Narula J, Fearon WF. Fractional flow reserve and coronary computed tomographic angiography: a review and critical analysis. Circ Res. 2016 Jul;119(2):300–316. doi: 10.1161/CIRCRESAHA.116.307914
- Douglas PS, Pontone G, Hlatky MA, et al. Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts. Eur Heart J. 2015 Dec;36(47):3359–3367.
- Patel MR, Nørgaard BL, Fairbairn TA, et al. 1-year impact on medical practice and clinical outcomes of FFR(CT): the ADVANCE registry. JACC: Cardiovasc Imaging. 2020 Jan;13(1):97–105.
- Curzen N, Nicholas Z, Stuart B, et al. Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial. Eur Heart J. 2021 Oct;42(37):3844–3852. doi: 10.1093/eurheartj/ehab444
- Douglas PS, Nanna MG, Kelsey MD, et al. Comparison of an initial risk-based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized clinical trial. JAMA Cardiol. 2023 Oct;8(10):904–914.
- Fairbairn F. CT FFR in stable heart disease and coronary computed tomographic angiography helps improve patient care and societal costs. Eur Heart J. 2023;44(Supplement_2):ehad655.161. doi:10.1093/eurheartj/ehad655.161
- Lee JM, Choi G, Koo BK, et al. Identification of high-risk plaques destined to cause acute coronary syndrome using coronary computed tomographic angiography and computational fluid dynamics. JACC Cardiovasc Imaging. 2019 Jun;12(6):1032–1043.
- Meah MN, Tzolos E, Wang KL, et al. Plaque burden and 1-year outcomes in acute chest pain: results from the multicenter RAPID-CTCA trial. JACC Cardiovasc Imaging. 2022 Nov;15(11):1916–1925.
- Meah MN, Bularga A, Tzolos E, et al. Distinguishing type 1 from type 2 myocardial infarction by using CT coronary angiography. Radiol Cardiothorac Imaging. 2022 Oct;4(5):e220081.
- Kwiecinski J, Tzolos E, Williams MC, et al. Noninvasive coronary atherosclerotic plaque imaging. JACC Cardiovasc Imaging. 2023 Dec;16(12):1608–1622.
- Emfietzoglou M, Mavrogiannis MC, Samaras A, et al. The role of cardiac computed tomography in predicting adverse coronary events. Front Cardiovasc Med. 2022;9:920119. doi: 10.3389/fcvm.2022.920119
- Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet (London, England). 2018 Sep;392(10151):929–939. doi: 10.1016/S0140-6736(18)31114-0
- Koo B-K. Artificial intelligence-enabled quantitative plaque and hemodynamic analysis for predicting acute coronary syndrome risk and prevention strategy: the EMERALD II Study. TCT Conf. USA, 2023.
- West HW, Siddique M, Williams MC, et al. Deep-learning for epicardial adipose tissue assessment with computed tomography: implications for cardiovascular risk prediction. JACC Cardiovasc Imaging. 2023;16(6):800–816. doi: 10.1016/j.jcmg.2022.11.018